CLINICAL OUTCOME OF SACRAL CHORDOMA WITH CARBON ION RADIOTHERAPY COMPARED WITH SURGERY
CLINICAL OUTCOME OF SACRAL CHORDOMA WITH CARBON ION RADIOTHERAPY COMPARED WITH SURGERY
复制标题
DOI:
10.1016/j.ijrobp.2009.10.051
复制
发表时间:
2011-01-01
影响因子:
7
通讯作者:
Ishiguro, Naoki
中科院分区:
文献类型:
--
作者:
Nishida, Yoshihiro;Kamada, Tadashi;Ishiguro, Naoki
Purpose: To evaluate the efficacy, post-treatment function, toxicity, and complications of carbon ion radiotherapy (RT) for sacral chordoma compared with surgery.Methods and Materials: The records of 17 primary sacral chordoma patients treated since 1990 with surgery (n = 10) or carbon ion RT (n = 7) were retrospectively analyzed for disease-specific survival, local recurrence-free survival, complications, and functional outcome. The applied carbon ion dose ranged from 54.0 Gray equivalent (GyE) to 73.6 GyE (median 70.4).Results: The mean age at treatment was 55 years for the surgery group and 65 years for the carbon ion RT group. The median duration of follow-up was 76 months for the surgery group and 49 months for the carbon ion RT group. The local recurrence-free survival rate at 5 years was 62.5% for the surgery and 100% for the carbon ion RT group, and the disease-specific survival rate at 5 years was 85.7% and 53.3%, respectively. Urinary-anorectal function worsened in 6 patients (60%) in the surgery group, but it was unchanged in all the patients who had undergone carbon ion RT. Postoperative wound complications requiring reoperation occurred in 3 patients (30%) after surgery and in 1 patient (14%) after carbon ion RT. The functional outcome evaluated using the Musculoskeletal Tumor Society scoring system revealed 55% in the surgery group and 75% in the carbon ion RT group. Of the six factors in this scoring system, the carbon ion RT group had significantly greater scores in emotional acceptance than did the surgery group.Conclusion: Carbon ion RT results in a high local control rate and preservation of urinary-anorectal function compared with surgery. (C) 2011 Elsevier Inc.